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Abstract
Introduction
While individuals tend to show accumulation of certain lifestyle patterns, the effect of such
patterns in real daily life on cardio-renal—metabolic parameters remains largely unknown.
This study aimed to assess clustering of lifestyle patterns and investigate the relationships
between such patterns and cardio-renal-metabolic parameters.
Participants and methods
The study participants were 726 Japanese type 2 diabetes mellitus (T2DM) outpatients free
of history of cardiovascular diseases. The relationship between lifestyle patterns and cardio-
renal-metabolic parameters was investigated by linear and logistic regression analyses.
Results
Factor analysis identified three lifestyle patterns. Subjects characterized by evening type,
poor sleep quality and depressive status (type 1 pattern) had high levels of HbA1c, alanine
aminotransferase and albuminuria. Subjects characterized by high consumption of food,
alcohol and cigarettes (type 2 pattern) had high levels of γ-glutamyl transpeptidase, triglyc-
erides, HDL-cholesterol, blood pressure, and brachial-ankle pulse wave velocity. Subjects
characterized by high physical activity (type 3 pattern) had low uric acid and mild elevation
of alanine aminotransferase and aspartate aminotransferase. In multivariate regression
analysis adjusted by age, gender and BMI, type 1 pattern was associated with higher HbA1c
levels, systolic BP and brachial-ankle pulse wave velocity. Type 2 pattern was associated
with higher HDL-cholesterol levels, triglycerides, aspartate aminotransferase, ɤ- glutamyl
transpeptidase levels, and diastolic BP.
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Conclusions
The study identified three lifestyle patterns that were associated with distinct cardio-meta-
bolic-renal parameters in T2DM patients.
Trial registration
UMIN000010932
Introduction
The incident of type 2 diabetes mellitus (T2DM) is related to numerous lifestyle problems.
Furthermore, the incidence of cardiovascular disease (CVD) and diabetes related microvasu-
clar events is strongly related with lifestyle factors in patients with T2DM [1,2]. Lifestyle modi-
fications such as a reduction in energy intake and an increase in physical activity can reduce
the onset of T2DM [3] in non-T2DM population and the development of CVD in T2DM
patients [4,5]. On the other hand, the reported effects of these interventions on the risks were
very modest. Furthermore, a recent clinical trial that focused on the control of energy intake
and increased physical activity in obese patients with T2DM showed no effect for lifestyle
intervention on CVD [6]. In this regard, much attention should be paid to lifestyles other than
diet and physical activity as lifestyle problems that could affect future CVD.
Recent studies have demonstrated the importance of sleep duration and/or quality as life-
style factors, based on findings confirming the pathological roles of these factors in the onset
of T2DM [7] and CVD [8]. Other studies reported that both sleep duration and/or quality can
affect cardiovascular risk factors in T2DM patients [9–11].
Morningness-eveningness reflects the timing of the sleep-wake pattern and different aspects
of sleep duration and/or quality, which are quite variable among individuals. In individuals of
the evening type, social rhythms do not synchronize with the circadian clock. Previous studies
demonstrated that evening type individuals tend to have unhealthy eating habits, behavioral
health problems, and sleep complains more than morning type subjects [12,13]. More recently,
we found inadequate glycemic control in evening type patients with T2DM [14] [15]. These
findings suggest that evening type individuals potentially have impaired metabolism by abnor-
mal circadian rhythm.
The prevalence of depression is reportedly higher in T2DM patients than non-T2DM [16].
Given that T2DM-related depression is related to poor glycemic control [17] and micro- and
macro-vascular complications [18], partly due to increased counter-regulatory hormones [19],
the depression status may be an important risk factor for defective glycemic control and
T2DM-related complications in patients with T2DM.
In daily life, people have variable lifestyle patterns that can influence their cardio-renal-met-
abolic parameters. In this regard, it is conceivable that certain specific lifestyle patterns tend to
accumulate in individual patients with T2DM. If we can classify the patients according to such
accumulated lifestyle patterns, it would be useful to design treatment strategies tailored to the
individual patients with T2DM. The aim of the present study was to explore possible classifica-
tion of patients with T2DM free of history of CVD, according to clustering of lifestyle factors
and mental status by factor analysis. We then investigated the relationships between each clus-
ter of lifestyle factors (e.g., circadian rhythm, habitual sleep, mental state, diet, alcohol con-
sumption, cigarettes consumption, physical activity) and cardio-renal—metabolic parameters,
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including brachial-ankle pulse wave velocity (baPWV), which is considered a useful predictor
of CVD [20].
Materials and methods
Patients
The subjects of this cohort study were recruited from the Diabetes Outpatient Clinic of Jun-
tendo University, (Tokyo, Japan) Naka Memorial Clinic (Naka, Japan) or Secomedic Hospital
(Funabashi, Japan) as previously described [15] [21] [22]. T2DM patients who were between
25 and 70 years of age without history of apparent CVD were included.
A total of 1,032 consecutive subjects were screened as previously described [15]. Briefly,
among them, 906 patients who met the above eligibility criteria were invited to participate in
the present study. After providing information on the purpose and procedures of the study,
736 patients with T2DM were recruited. The study was approved by the Institutional Review
Board of Juntendo University Hospital and conducted in accordance with the principles
described in the Declaration of Helsinki. All patients provided written informed consent prior
to participation. The study has been registered on the University Hospital Medical Informa-
tion Network Clinical Trials Registry (UMIN000010932).
Questionnaire survey
Questionnaire survey was conducted using valid and reliable self-administered questionnaires
described previously [15]. Briefly, we used the Morning Evening Questionnaire (MEQ) [23],
which is a self-assessment questionnaire developed primarily for screening candidates for
sleep-related experiments to evaluate morningness and eveningness in individuals. A high
MEQ score represents morning type.
The Pittsburg Sleep Quality Index (PSQI) [24] is a self-administered questionnaire designed
to evaluate sleep quality and consists of 18 items that in turn are comprised of 7 components,
with each weighted equally on a 0–3 scale to be summed to yield the global PSQI score ranging
from 0 to 21, where the higher the scores, the worse the sleep quality.
The participating patients also completed the BDI (Beck Depression inventory)-II, which is
a 21-item questionnaire [25]. A high BDI score represents depressive state.
Dietary habits during the preceding month were assessed with the validated, Brief, self-
administered Diet History Questionnaire (BDHQ). The BDHQ is a 4-page structured ques-
tionnaire that asks about consumption frequency of selected foods to estimate the dietary
intake of 56 food and beverage items with specified serving size described in terms of con-
sumption in general Japanese populations[26].
Physical activity level was assessed with the International Physical Activity Questionnaire
(IPAQ) that comprises four simple questions on physical activity [27]. The IPAQ results are
expressed as metabolic equivalent scores (METshour-week−1).
Workers were defined as full-time employees or shift workers by a question in the question-
naire as described previously [15]. The subjects were also divided into non-smokers, former
smokers or current smokers, as described previously[15]. Estimation of the total number of
cigarettes was calculated by cigarettes smoked per day times smoking duration (years).
Biochemical tests
Blood samples were obtained at visits after overnight fast. Liver and renal function tests, lipids,
HbA1c, and glucose, (National Glycohemoglobin Standardization Program) were measured
with standard techniques. Urinary albumin excretion (UAE) was measured by latex
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agglutination assay using a spot urine sample. The estimated glomerular filtration rate (eGFR)
was calculated by the formula: eGFR (ml/min per 1.73 m2) = 194× Age-0.287× serum creati-
nine-0.1094 (×0.739 for females) [28].
Measurement of baPWV
baPWV was measured using an automatic waveform analyzer (BP-203RPE; Colin Medical
Technology, Komaki, Japan), as described previously [15] [29]. All scans were automatically
conducted by well-trained investigators who were blinded to the clinical information.
Statistical analysis
Results are presented as mean±SD or median (interquartile range: 25% to 75%) for continuous
variables or number (proportion) of patients for categorical variables. Some parameters were
logarithmically transformed to approximate a normal distribution. We used factor analysis
with oblique promax rotation to reduce the complexity of lifestyle patterns of patients with
T2DM by morningness-eveningness, quality of sleep including sleep duration, depressive sta-
tus, energy intake, alcohol consumption, cigarettes smoking, and physical activity. Factors
with an eigenvalue >1 were retained. Individual metabolites with a factor loading of>|0.3| are
reported as composing that factor for simplicity. The factor scores for each lifestyle pattern
and for each subject were calculated by summing each lifestyle score weighted by their factor
loadings. The estimated factor scores were categorized into quintiles. Trend association across
the quintile was evaluated by linear regression analysis for continuous variables and logistic
regression analysis for categorical variables. We developed three models to evaluate the trend.
The first model was unadjusted, second model was adjusted for age and gender, and third
model adjusted for age, gender, and body mass index (BMI). The model for eGFR was only
adjusted for BMI. Multivariate regression analysis adjusting for age, gender and BMI was per-
formed to investigate what types of lifestyle patterns identified in this study were related with
cardio-renal-metabolic parameters. Statistical tests were two-sided with 5% significant level.
All analyses were performed using the SAS software version 9.3 (SAS Institute, Cary, North
Carolina).
Results
Ten patients were thus excluded from analysis because they did not complete the question-
naires among 736 patients. The characteristics of 726 subjects were shown in Table 1. The
mean age was 57.8±8.6 years, 62.9% male and HbA1c was 7.0±1.0%. Glucose and lipid metab-
olisms and BP were well controlled in those subjects.
Factor analysis with oblique promax rotation identified three life style patterns (Table 2).
Factor 1 seemed to be characterized by morningness-eveningness, sleep quality and depressive
status (Type 1 pattern), Factor 2 by consumption of food, alcohol and cigarettes (Type 2 pat-
tern), and Factor 3 by physical activity (Type 3 Pattern).
The characteristics across quintile of lifestyle pattern on each type are shown in Tables 3–5.
Table 3 shows the characteristics of the study subjects based on the quintiles of type 1 pattern
scores. Subjects with a higher score for this pattern represent more evening type, poor sleep
quality, and depressive status. They tended to be young, female, and worker or shift worker in
the unadjusted model. Also, they tended to go to bed late, wake up late and sleep for shorter
time. In addition, those patients tended to have less frequently have breakfast, and have late
dinner, and late breakfast, frequently have late evening snacks, and consumption of large
amount of food. These findings suggest they seem to consume greater percentage of their daily
energy at late time. In addition, they has significantly higher BMI, alanine aminotransferase
Lifestyle patterns and cardio-renal-metabolic parameters
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Table 1. Patients characteristics (n = 726).
Demographic data
Age (years) 57.8±8.6
Gender (male) 456 (62.9)
Estimated duration of diabetes (years) 9.9±7.2
Body mass index (kg/m2) 24.6±4.1
HbA1c (%) 7.0±1.0
HbA1c (mmol/mol) 52.5±10.8
Fasting blood glucose (mg/dl) 134±31
Systolic blood pressure (mmHg) 127±14
Diastolic blood pressure (mmHg) 77±11
Total cholesterol (mg/dL) 185±28
HDL-cholesterol (mg/dL) 59±14
Triglyceride (mg/dL) 100 [70, 152]
AST (U/L) 21 [18, 27]
ALT (U/L) 22 [16, 33]
ɤ-GTP (U/L) 25 [17, 39]
Uric Acid (mg/dl) 5.5 ± 1.2
eGFR (ml/min/ 1.73 m2) 78 ± 18
UAE (mg/g creatinine) 10 [6, 23]
baPWV (cm/s) 1543± 279
Morningness-Eveningness Questionnaire 57.4 ± 7.3
Pittsburg Sleep Quality Index 5.1 ± 3.0
Beck Depression inventory -II 9.9 ± 7.6
Energy intake (kcal/day) 1713±582
Physical activity (Metsh/week) 42.8±70.5
Sleep duration (hours) 6.4±1.2
Number of cigarettes 335±458
Current smoker (yes) 174 (24.0)
Alcohol (g/day) 12.3±21.5
On treatment for (n/%)
Diabetes 620 (85.5)
Hypertension 346 (47.7)
Hyperlipidemia 442 (61.0)
Data are mean±SD or number (proportion) of patients. ALT: alanine aminotransferase; AST: aspartate
aminotransferase; baPWV: brachial-ankle pulse wave velocity; eGFR: estimated glomerular filtration rate,
HDL-C: high-density lipoprotein-cholesterol, UAE, urinary albumin excretion, ɤ-GTP, ɤ-glutamyl
transpeptidase.
doi:10.1371/journal.pone.0173540.t001
Table 2. Life style items and factor analysis with oblique promax rotation.
Components and item labels Factor 1 Factor 2 Factor 3
Morningness Eveningness Questionnaire -0.62 0.12 0.21
Pittsburg Sleep Quality Index 0.78 0.02 0.08
Beck Depression inventory 0.71 0.06 0.01
Energy intake 0.12 0.64 0.29
Smoking -0.05 0.65 -0.22
Alcohol intake -0.05 0.81 -0.04
International Physical Activity Questionnaire -0.05 -0.06 0.93
Contribution 22% 21% 14%
doi:10.1371/journal.pone.0173540.t002
Lifestyle patterns and cardio-renal-metabolic parameters
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Table 3. Characteristics according to quintile categories of type 1 life style pattern score.
Variable Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Est1 Est2 Est3
MEQ 64.6 ± 4.9 60.2 ± 4.9 56.5 ± 5.7 54.4 ± 6.4 51.4 ± 6.4 -3.22¶ -2.96¶ -2.95¶
PSQI 2.6 ± 1.3 3.7 ± 1.4 4.6 ± 1.7 5.9 ± 2.1 8.7 ± 3.6 1.45¶ 1.49¶ 1.48¶
BDI 3.6 ± 3.6 6.6 ± 4.6 8.3 ± 4.8 11.9 ± 5.7 19.0 ± 8.1 3.61¶ 3.72¶ 3.72¶
Energy intake (kcal/day) 1609 ± 463 1709 ± 535 1650 ± 567 1811 ± 559 1782 ± 733 44.6† 68.7¶ 68.6¶
Smoking (number) 388 ± 466 318 ± 453 357 ± 519 328 ± 460 279 ± 379 -20.8 12.5 11.9
Alcohol (g/day) 16.2 ± 23.2 11.8 ± 19.6 9.6 ± 21.6 13.0 ± 21.3 10.5 ± 21.3 -1.04 -0.01 -0.06
Physical activity (Metsh/week) 47.5 ± 60.8 38.2 ± 56.4 45.7 ± 77.0 43.0 ± 81.6 40.1 ± 74.8 -1.00 -0.02 0.27
Age (years) 61.2 ± 6.3 59.8 ± 7.6 56.9 ± 8.8 56.1 ± 9.3 54.8 ± 9.0 -1.65¶ - -
Gender (male) 107 (74.3) 95 (66.0) 83 (57.6) 93 (64.6) 73 (50.7) -0.21¶ - -
Body mass index (kg/m2) 23.9 ± 3.5 23.9 ± 3.7 24.8 ± 4.2 24.8 ± 3.8 25.8 ± 4.7 0.46¶ 0.18 -
Estimated duration of diabetes
(years)
10.3 ± 7.4 9.4 ± 6.3 8.6 ± 7.8 10.8 ± 7.6 10.4 ± 6.7 0.17 0.58 0.62
Anti-diabetes medications
(yes)
123(85.4) 121(84.0) 121(84.0) 126(87.5) 125(86.8) 0.05 0.07 0.07
Anti-hypertensives (yes) 67(46.5) 72(50.0) 59(41.0) 73(50.7) 73(50.7) 0.04 0.08 0.06
Lipid-lowering agents (yes) 86(59.7) 90(62.5) 90(62.5) 86(59.7) 88(61.1) 0.00 0.01 0.00
Working (yes) 96(66.7) 101(70.1) 106(73.6) 110(76.4) 116(80.6) 0.18† 0.15* 0.15*
Shift worker (yes) 9(6.3) 16(11.1) 13(9.0) 19(13.2) 20(13.9) 0.18* 0.07 0.08
Sleep duration (hours) 7.1±1.1 6.7±0.9 6.4±1.0 6.2±1.2 5.9±1.2 0.07* 0.02 0.02
Wake time, A.M. 5:30[5:00,6:00] 6:00[5:18,6:30] 6:00[5:30,6:30] 6:00[5:30,6:30] 6:18[5:30,7:00] -0.30¶ -0.27¶ -0.27¶
Bed time, P.M. 22:15
[21:30,23:00]
23:00
[22:00,23:30]
23:08
[22:20,24:00]
23:15
[22:30,24:00]
23:50
[23:00,24:30]
0.19¶ 0.18¶ 0.18¶
Breakfast time, A.M. 7:00[6:15,7:18] 7:00[6:30,7:30] 7:00[6:30,7:30] 7:00[6:30,7:30] 7:20[6:40,8:00] 0.33¶ 0.24¶ 0.24¶
Dinner time, P.M. 19:00
[18:30,19:30]
19:00
[18:30,19:30]
19:00
[19:00,20:00]
19:00
[18:30,20:00]
19:30
[19:00,20:00]
0.14¶ 0.13¶ 0.13¶
Number of breakfasts (/week) 6.9±0.6 6.8±0.8 6.7±0.9 6.5±1.4 6.0±1.9 0.18¶ 0.14¶ 0.13¶
Late evening snack (yes) 38 (26.4) 50 (34.7) 68 (47.2) 68 (47.2) 64 (44.4) 0.21¶ 0.22¶ 0.22¶
AST (U/L) 21 [18,27] 21 [18,27] 22 [17,25] 21 [18,26] 21 [18,28] 0.00 0.00 0.00
ALT (U/L) 21 [16,31] 23 [16,35] 22 [16,32] 24 [17,34] 24 [16,38] 0.04¶ 0.03* 0.02
ɤ-GTP (U/L) 25 [17,36] 24 [17,35] 25 [18,40] 27 [18,46] 22 [15,42] 0.02 0.02 0.01
Uric Acid (mg/dl) 5.5 ± 1.2 5.5 ± 1.2 5.5 ± 1.2 5.5 ± 1.3 5.4 ± 1.3 -0.01 0.00 -0.01
eGFR (ml/min/ 1.73 m2) 76 ± 18 78 ± 18 79 ± 17 77 ± 18 80 ± 17 0.72 - 0.51
Total cholesterol (mg/dl) 186 ± 25 185 ± 31 186 ± 30 183 ± 26 187 ± 27 0.03 -0.45 -0.55
HDL-C (mg/dl) 62 ± 15 59 ± 15 59 ± 14 57 ± 14 59 ± 13 -0.59 -0.46 -0.30
Triglycerides (mg/dl) 94 [66,146] 98 [67,145] 96 [69, 139] 112 [77, 164] 104 [73, 152] 0.03* 0.02 0.01
Fasting blood glucose (mg/dl) 127 ± 28 134 ± 32 131 ± 27 136 ± 32 141 ± 34 2.90¶ 2.29† 2.21*
HbA1c (%) 6.7 ± 0.8 6.9 ± 1.0 6.9 ± 1.0 7.1 ± 1.1 7.1 ± 1.1 0.11¶ 0.07† 0.07*
HbA1c (mmol/mol) 49.5±8.3 52.4±10.8 52.2±10.5 54.0±12.0 54.6±11.6
Systolic BP (mmHg) 127 ± 15 125 ± 14 125 ± 14 127 ± 13 129 ± 15 0.61 0.71 0.52
Diastolic BP (mmHg) 77 ± 13 76 ± 10 76 ± 10 78 ± 11 78 ± 12 0.36 0.08 -0.04
UAE (mg/g creatinine) 10 [6, 21] 9[6, 15] 10 [6, 24] 11 [6, 35] 11 [6, 26] 0.06 0.08* 0.07
(Continued)
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(ALT) levels, HbA1c levels and fasting blood glucose levels in the unadjusted model. Further-
more, fasting blood glucose and HbA1c levels were significantly higher in patients with higher
scores of type 1 pattern even in the model adjusted for age, gender and BMI. Also, ALT and
UAE were higher in the adjusted model by age and gender.
Table 4 lists the characteristics of the study subjects based on the quintiles of type 2 pattern
scores. Subjects with a higher score of this pattern tended to be old, males, current smokers,
and workers or shift workers in the unadjusted model. Furthermore, these patients tended to
go to bed early, wake up early and eat breakfast early. Accordingly, they tended to be morning
type, but less frequently had breakfast. With regard to the cardio-metabolic parameters,
patients with higher score of type 2 pattern showed significantly higher aspartate aminotrans-
ferase (AST) levels, ɤ-glutamyl transpeptidase (ɤ-GTP) levels, uric acid and triglycerides.
These data reflect patterns of alcoholic liver dysfunction, while there was no significant differ-
ence in BMI among the groups. On the other hand, HbA1c levels were significantly lower in
these patients in the unadjusted model, but this finding was not observed in the adjusted
model. The use of lipid-lowering medications, especially statin but not fibrate (data not
shown), was lower in patients with a higher score of type 2 pattern. With regard to BP, these
patients had high systolic and diastolic BP despite high use of antihypertensive drugs. Also,
baPWV was significantly higher in those patients. According to the adjusted models by age
and gender and by age, gender, and BMI, subjects with a higher score for this pattern had
higher ɤ-GTP, triglyceride, HDL-cholesterol levels, systolic and diastolic BP, and baPWV.
Table 5 shows the characteristics of the study subjects according to the quintiles of type 3
pattern scores. Subjects with a higher score for this pattern were old, non-smokers, shift work-
ers, and morning type. These patients are likely to have low BMI despite the large amount of
food intake. They tended to go to bed early, wake up early, sleep for short duration and have
early dinner. Patients with a higher score of type 3 pattern showed significantly lower uric
acid, triglyceride and diastolic BP, and higher HDL-cholesterol. However, these subjects only
had lower uric acid levels, rather higher AST and ALT, in the adjusted models by age and gen-
der and by age, gender and BMI. They also had higher AST and ALT, and were less likely to
use antihypertensive medication, in the adjusted model by age and gender.
Next, we performed a multivariate regression analysis to investigate whether three types of
lifestyle patterns identified in this study were related with cardio-renal-metabolic parameters
Table 3. (Continued)
Variable Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Est1 Est2 Est3
baPWV (cm/s) 1582 ± 304 1563 ± 302 1514 ± 274 1540 ± 266 1517 ± 246 -15.31 9.56 9.90
Data are mean±SD, median [range: 25% to 75%] or number of subjects (proportion) before adjustment. Est1: Trend estimation for linear trends across
quintiles is based on linear regression analysis for continuous variables or logistic regression analysis for categorical variables. Est2: Trend estimation for
linear trends across quintiles is based on linear regression analysis for continuous variables or logistic regression analysis for categorical variables adjusted
for age and gender. Est3: Trend estimation for linear trends across quintiles is based on linear regression analysis for continuous variables or logistic
regression analysis for categorical variables adjusted for age, gender and BMI. eGFR is adjusted for BMI.
*P<0.05,
†P<0.01,
¶P<0.001 for testing the trend.
For trend test, log-transformed AST, ALT,ɤ-GPT, UAE, and TG. ALT: alanine aminotransferase; AST: aspartate aminotransferase; baPWV: brachial-ankle
pulse wave velocity; BP: blood pressure; BDI: Beck Depression inventory, eGFR: estimated glomerular filtration rate, Est, estimation of regression
coefficient, HDL-C: high-density lipoprotein-cholesterol, MEQ: morningness-eveningness questionnaire, PSQI: Pittsburg Sleep Quality Index, UAE, urinary
albumin excretion,ɤ-GTP,ɤ-glutamyl transpeptidase.
doi:10.1371/journal.pone.0173540.t003
Lifestyle patterns and cardio-renal-metabolic parameters
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Table 4. Characteristics according to quintile categories of type 2 pattern score.
Variable Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Est1 Est2 Est3
MEQ 55.3 ± 7.2 57.6 ± 7.0 57.0 ± 7.4 57.7 ± 6.4 59.6 ± 7.9 0.87† 0.62* 0.63*
PSQI 5.1 ± 3.4 5.1 ± 2.9 4.9 ± 2.5 5.6 ± 3.5 4.9 ± 2.9 0.00* 0.24* 0.23*
BDI 9.1 ± 7.9 10.6 ± 8.1 9.8 ± 7.4 9.6 ± 7.8 10.3 ± 7.2 0.12 0.75† 0.75†
Energy intake (kcal/day) 1144 ± 241 1531 ± 272 1711 ± 385 1913 ± 480 2262 ± 707 261.7¶ 302.61¶ 302.9¶
Smoking (number) 25 ± 79 88 ± 186 284 ± 314 446 ± 346 827 ± 615 196.3¶ 168.3¶ 168.1¶
Current smoker (yes) 11 (7.6) 19 (13.2) 39 (27.1) 51 (35.4) 50 (34.7) 0.45¶ 0.38¶ 0.39¶
Alcohol (g/day) 0.6 ± 2.1 0.8 ± 2.3 3.9 ± 6.5 12.4 ± 13.0 43.3 ± 28.1 9.71¶ 9.62¶ 9.61¶
Physical activity (Metsh/
week)
41.4 ± 68.1 38.5 ± 61.3 47.3 ± 68.9 40.2 ± 65.5 47.2 ± 87.1 1.31 0.37 0.60
Age (years) 56.7 ± 9.5 57.5 ± 8.5 57.3 ± 8.5 57.3 ± 8.7 59.9 ± 7.3 0.62† - -
Gender (male) 35 (24.3) 63 (43.8) 90 (62.5) 126 (87.5) 137 (95.1) 1.01¶ - -
Body mass index (kg/m2) 24.6 ± 4.1 24.9 ± 4.0 24.4 ± 4.4 24.9 ± 4.1 24.4 ± 3.6 -0.04 0.14 -
Estimated duration of
diabetes (years)
9.5±8.3 10.2±6.8 9.3±6.3 9.8±6.9 10.8±7.6 0.24 0.13 0.16
Anti-diabetes medications
(yes)
127(88.2) 124(86.1) 119(82.6) 122(84.7) 124(86.1) -0.04 -0.10 -0.09
Anti-hypertensives (yes) 68(47.2) 60(41.7) 56(38.9) 70(48.6) 90(62.5) 0.15† 0.17† 0.16*
Lipid-lowering agents (yes) 97(67.4) 96(66.7) 91(63.2) 83(57.6) 73(50.7) -0.18† -0.15* -0.16*
Working (yes) 100(69.4) 90(62.5) 108(75.0) 117(81.3) 114(79.2) 0.20† 0.04 0.05
Shift worker (yes) 22(15.3) 13(9.0) 18(12.5) 19(13.2) 5(3.5) -0.21* -0.03 -0.02
Sleep duration (hours) 6.4±1.1 6.4±1.1 6.4±1.1 6.4±1.0 6.7±1.3 0.07* 0.01 0.01
Wake time, A.M. 6:00[5:30,7:00] 6:00[5:25,6:30] 6:00[5:30,6:30] 6:00[5:30,6:30] 6:00[5:00,6:30] -0.11† -0.15† -0.16¶
Bed time, P.M. 23:00
[22:30,24:00]
23:00
[22:00,24:00]
23:00
[22:30,23:50]
23:00
[22:00,23:50]
22:30
[21:30,23:30]
-0.12† -0.04 -0.04
Breakfast time, A.M. 7:00[6:30,7:45] 7:00[6:30,7:40] 7:00[6:25,7:30] 7:00[6:30,7:30] 7:00[6:30,7:30] -0.08† -0.02 -0.02
Dinner time, P.M. 19:20
[18:30,20:00]
19:00
[18:30,19:30]
19:00
[18:30,19:40]
19:00
[18:30,20:00]
19:00
[18:30,20:00]
0.00 -0.01 -0.01
Number of breakfasts
(/week)
6.6±1.1 6.7±1.0 6.6±1.3 6.7±1.1 6.4±1.7 -0.05 -0.05 -0.04
Late evening snack (yes) 47(32.6) 64(44.4) 73(50.7) 60(41.7) 44(30.6) -0.03 0.04 0.04
AST (U/L) 21 [18,26] 21 [18,26] 20 [17,25] 22 [17,28] 23 [20,29] 0.02* 0.02 0.02
ALT (U/L) 20 [15,31] 21 [16,34] 22 [16,29] 25 [17,35] 24 [17,34] 0.02 0.02 0.02
ɤ-GTP (U/L) 21 [15,32] 24 [16,35] 22 [15,36] 27 [20,44] 35 [22,57] 0.11¶ 0.08¶ 0.07¶
Uric Acid (mg/dl) 5.2 ± 1.2 5.3 ± 1.2 5.3 ± 1.2 5.8 ± 1.3 5.9 ± 1.1 0.20¶ 0.04 0.03
eGFR (ml/min/ 1.73 m2) 79 ± 19 77 ± 18 80 ± 20 77 ± 16 77 ± 17 -0.42 - -0.40
Total cholesterol (mg/dl) 187 ± 27 188 ± 28 185 ± 30 184 ± 28 182 ± 26 -1.29 0.81 0.73
HDL-C (mg/dl) 62 ± 13 59 ± 14 58 ± 15 57 ± 14 61 ± 14 -0.25 1.11† 1.24†
Triglycerides (mg/dl) 94 [67, 130] 99 [69, 146] 104[74, 139] 108 [72, 157] 117 [70, 165] 0.04† 0.05† 0.04*
Fasting blood glucose (mg/
dl)
134 ± 33 135 ± 35 128 ± 23 134 ± 30 138 ± 32 0.84 1.04 0.98
HbA1c (%) 7.0 ± 1.1 7.1 ± 1.1 6.9 ± 0.8 7.0 ± 1.1 6.8 ± 0.9 -0.06* -0.02 -0.03
HbA1c (mmol/mol) 53.5±11.7 53.9±12.1 51.7±8.7 52.8±11.5 50.8±9.5
Systolic BP (mmHg) 128 ± 14 124 ± 14 124 ± 14 128 ± 15 129 ± 14 0.68 1.28† 1.13†
Diastolic BP (mmHg) 77 ± 9 74 ± 9 75 ± 11 79 ± 14 80 ± 10 1.11¶ 0.83* 0.74*
UAE (mg/g creatinine) 11 [7, 25] 11 [6, 21] 8 [5, 15] 9 [5, 21] 13 [7, 35] 0.03 0.07 0.06
(Continued)
Lifestyle patterns and cardio-renal-metabolic parameters
PLOS ONE | DOI:10.1371/journal.pone.0173540 March 8, 2017 8 / 16
(Table 6). Type 1 pattern was associated with higher HbA1c levels, systolic BP and baPWV.
Type 2 pattern was associated with higher HDL-cholesterol levels, triglycerides, AST, ɤ-GTP
levels, and diastolic BP.
Discussion
This is the first report on the relationship between clustered lifestyle, not a single aspect of life-
style, and cardio-renal-metabolic parameters in patients with T2DM. Using factor analysis,
lifestyle patterns in real daily life can be classified into three factors; morningness-eveningness,
sleep quality and depressive state (type 1 pattern), consumption of food, alcohol and cigarettes
(type 2 pattern), and physical activity (type 3 pattern). Interestingly, each lifestyle is associated
with distinct cardio-renal -metabolic parameters.
Subjects with a higher score of type 1 pattern characterized by evening type, poor sleep
quality and depressive status showed poor glycemic control and higher ALT and UAE levels in
this study. It may be reasonable that these characteristics correlated well with each other
because previous reports showed a tendency for such association[14] [15]. These individuals
tend to have later dinners, frequent late evening snacks, and less frequent breakfast and con-
sume more food. They were considered to consume a greater amount of their daily energy
intake at late time of the day. A previous study demonstrated that late dinnertime increases in
postprandial glucose levels after breakfast in the following morning compared to usual dinner
time condition through a higher effect of late dinners on carbohydrate digestion and absorp-
tion of dietary carbohydrates [30]. Therefore, it seems that late eating could result in worsen-
ing of glycaemic control. In addition, consistent with our findings, evening type was shown to
be related to more depressive symptoms [31]. Depressive status may also negatively affect glu-
cose metabolism through increased counter-regulatory hormones [19].
Subjects with a higher score of type 1 pattern were more likely to be employed as workers,
with higher frequency of overtime work beyond 21:00 PM (data not shown). Such workers
may be often forced to stay awake through social cues against their preference. This may lead
to disruption of the circadian system. A previous study demonstrated that forced circadian
misalignment developed insulin resistance [32]. Therefore, circadian misalignment by envi-
ronmental elements may contribute to worsening of glycemic control in those patients.
Patients with T2DM are known to have sleep abnormalities compared with healthy subjects
[33]. In the present study, subjects with a higher score of type 1 pattern had poor sleep quality
and short sleep duration. Recent studies reported both sleep quality and/or duration have neg-
ative influence on glucose and lipid metabolism in T2DM patients [9–11]. Sleep has major
Table 4. (Continued)
Variable Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Est1 Est2 Est3
baPWV (cm/s) 1490 ± 245 1530 ± 281 1519 ± 271 1566 ± 272 1611 ± 313 278¶ 16.9* 17.1*
Data are mean±SD, median [range: 25% to 75%] or number of subjects (proportion) before adjustment. Est1: Trend estimation for linear trends across
quintiles is based on linear regression analysis for continuous variables or logistic regression analysis for categorical variables. Est2: Trend estimation for
linear trends across quintiles is based on linear regression analysis for continuous variables or logistic regression analysis for categorical variables adjusted
for age and gender. Est3: Trend estimation for linear trends across quintiles is based on linear regression analysis for continuous variables or logistic
regression analysis for categorical variables adjusted for age, gender and BMI. eGFR is adjusted for BMI.
*P<0.05,
†P<0.01,
¶P<0.001 for testing the trend.
For trend test, log-transformed AST, ALT,ɤ-GPT, UAE, and TG. See Table 3 for abbreviations.
doi:10.1371/journal.pone.0173540.t004
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Table 5. Characteristics according to quintile categories of type 3 life style pattern score.
Variable Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Est Est1 Est2
MEQ 53.6 ± 7.6 56.2 ± 6.2 58.5 ± 7.1 59.7 ± 6.7 59.1 ± 7.2 1.44¶ 1.31¶ 1.30¶
PSQI 4.4 ± 2.4 4.7 ± 2.6 5.4 ± 2.9 5.6 ± 3.2 5.5 ± 3.7 0.32¶ 0.32¶ 0.35¶
BDI 10.0 ± 7.5 10.0 ± 7.7 9.9 ± 7.3 9.0 ± 7.1 10.5 ± 8.7 0.00 0.03 0.04
Energy intake (kcal/day) 1354 ± 391 1538 ± 370 1680 ± 390 1968 ± 559 2022 ± 797 176.6¶ 179.8¶ 180.4¶
Smoking (number) 655 ± 636 300 ± 392 208 ± 329 255 ± 559 252 ± 323 -85.2¶ -85.8¶ -85.5¶
Alcohol (g/day) 8.9 ± 21.6 10.7 ± 19.6 11.0 ± 19.6 13.0 ± 23.9 13.6 ± 22.7 0.44 0.54 0.57
Physical activity (Metsh/
week)
8.9 ± 10.3 12.6 ± 11.9 19.2 ± 16.2 35.8 ± 24.4 138.1 ± 110.3 28.17¶ 28.22¶ 28.08¶
Age (years) 56.8 ± 8.4 56.9 ± 9.0 57.7 ± 8.1 58.6 ± 8.4 58.7 ± 8.9 0.56* - -
Gender male (%) 102 (70.8) 80 (55.6) 91 (63.2) 86 (61.1) 90 (62.5) -0.05 - -
Body mass index (kg/m2) 25.1 ± 4.2 24.6 ± 4.2 24.8 ± 4.1 24.8 ± 4.2 24.0 ± 3.6 -0.21* -0.12 -
Estimated duration of
diabetes (years)
9.4±6.1 10.1±7.2 9.4±7.0 10.3±8.0 10.5±7.6 0.24 0.12 0.10
Anti-diabetes medications
(yes)
127(88.2) 125(86.8) 120(83.3) 118(81.9) 126(87.5) -0.05 -0.05 -0.05
Anti-hypertensives (yes) 78(54.2) 67(46.5) 67(46.5) 77(53.5) 55(38.2) -0.10 -0.11* -0.10
Lipid-lowering medications
(yes)
87(60.4) 87(60.4) 91(63.2) 88(61.1) 87(60.4) 0.00 -0.01 -0.01
Working (yes) 113(78.5) 107(74.3) 98(68.1) 102(70.8) 109(75.7) -0.05 0.04 0.04
Shift worker (yes) 15(10.4) 10(6.9) 13(9.0) 18(12.5) 21(14.6) 0.15 0.18* 0.18*
Sleep duration (hours) 6.6±1.2 6.6±1.1 6.4±1.1 6.3±1.2 6.4±1.3 -0.07* -0.08† -0.08†
Wake time, A.M. 6:00[5:30,6:50] 6:00[5:30,6:30] 6:00[5:13,6:30] 6:00[5:30,6:30] 5:55[5:00,6:23] -0.10† -0.10* -0.09*
Bed time, P.M. 23:15
[22:30,24:20]
23:00
[22:20,24:00]
23:00
[22:08,23:45]
23:00
[22:00,23:50]
22:30
[22:00,23:30]
-0.16¶ -0.13¶ -0.13¶
Breakfast time, A.M. 7:00[6:30,8:00] 7:00[6:30,7:30] 7:00[6:30,7:30] 7:00[6:30,7:30] 7:00[6:25,7:30] -0.04 -0.05 -0.04
Dinner time, P.M. 19:30
[19:00,20:00]
19:00
[18:30,20:00]
19:00
[18:30,19:30]
19:00
[18:30,20:00]
19:00
[18:30,19:30]
-0.08† -0.06* -0.06*
Number of breakfasts
(/week)
6.2±1.8 6.7±0.8 6.7±1.1 6.7±1.1 6.6±1.3 0.08* 0.06 0.06
Late evening snack (yes) 60(41.7) 59(41.0) 53(36.8) 58(40.3) 58(40.3) -0.01 -0.02 -0.02
AST (U/L) 20 [17,26] 20 [17,27] 21 [18,26] 22 [19,27] 23 [19,27] 0.03† 0.03† 0.03†
ALT (U/L) 21 [16,33] 21 [16,29] 24 [17,35] 23 [17,34] 24 [16,33] 0.02 0.03* 0.04†
ɤ-GTP (U/L) 26 [18,43] 26 [17,38] 26 [17,43] 25 [18,36] 25 [16,38] -0.03 -0.02 -0.01
Uric Acid (mg/dl) 5.8 ± 1.2 5.3 ± 1.3 5.5 ± 1.3 5.5 ± 1.2 5.3 ± 1.1 -0.09† -0.07* -0.06*
eGFR (ml/min/ 1.73 m2) 79 ± 18 79 ± 17 78 ± 19 76 ± 16 78 ± 18 -0.48 - 0.37
Total cholesterol (mg/dl) 182 ± 28 187 ± 27 186 ± 27 187 ± 29 184 ± 29 0.48 0.35 0.41
HDL-C (mg/dl) 57 ± 14 60 ± 13 57 ± 14 60 ± 13 62 ± 15 0.87¶ 0.63 0.53
Triglycerides (mg/dl) 102 [81, 157] 97 [67, 162] 105 [71, 153] 100 [67, 145] 97 [66, 149] -0.03* -0.03 -0.02
Fasting blood glucose (mg/dl) 133 ± 32 135 ± 33 137 ± 32 131 ± 29 133 ± 29 -0.48 -0.13 -0.08
HbA1c (%) 6.9 ± 1.0 7.0 ± 1.0 7.0 ± 1.0 6.9 ± 1.0 7.0 ± 0.9 0.00 0.01 0.01
HbA1c (mmol/mol) 52.0±11.0 53.2±11.3 52.7±11.2 52.1±11.0 52.6±9.7
Systolic BP (mmHg) 127 ± 15 127 ± 15 125 ± 13 127 ± 13 126 ± 15 -0.23 -0.28 -0.15
Diastolic BP (mmHg) 79 ± 10 78 ± 11 77 ± 11 77 ± 13 75 ± 11 -0.72* -0.52 -0.45
UAE (mg/g creatinine) 10 [6, 24] 10 [6, 22] 10 [5, 25] 10 [6, 21] 10 [6, 21] -0.03 -0.03 -0.02
(Continued)
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regulatory effects on metabolic function, hormone release and sympathovagal activity. Indeed,
sleep deprivation is reported to be associated with low levels of circulating satiety hormone lep-
tin, high levels of appetite stimulating hormone ghrelin [34] and high sympathetic activity
[35]. These changes are expected to be deleterious for glycaemic control. Taken together, our
findings suggest the synergistic deleterious effects of these unfavourable traits on glycemic
control in patients with T2DM. In fact, our multivariate regression analysis suggested that type
1 pattern was associated with higher HbA1c levels even considering other lifestyle patterns.
Thus, optimizing these unfavourable habits should be investigated as an intervention to
improve glucose control in patients with T2DM.
Subjects with a higher score of type 1 pattern had high UAE levels. The high levels of UAE
could be due to poor glycemic control and potentially high sympathetic activity. Due to the
presence of accumulated risk factors for atherosclerosis, type 1 pattern was associated with
increased atrial stiffness in the multivariate regression model.
Subjects with a high score of type 2 pattern reported high consumption of food, alcohol and
cigarettes. Especially, they had high ɤ-GTP, uric acid, and triglyceride levels. These findings
suggest the presence of alcohol-related metabolic dysfunctions. Also, the results of the multi-
variate regression analysis supported these findings. It is also plausible that the high BP found
in these patients was due to the high consumption of alcohol and cigarette [36].
In general, subjects preferring eveningness have been shown to make a custom of adverse
health behaviors such as smoking, alcohol use, and physical inactivity compared to those pre-
ferring morningness in the general population [37]. In contrast, subjects with a high score of
type 2 pattern showed morning type despite having unfavourable habits such as high con-
sumption of alcohol and cigarettes. The exact reason(s) for this discrepancy is (are) not clear at
present. However, short sleep duration was reported to be associated with high alcohol con-
sumption [38]. In this study, subjects with a high score of this pattern reported short sleep
duration. The latter could adversely affect the classification of morningness-eveningness.
Our study also identified a unique clustered lifestyle characterized by physical activity. The
results of multivariate adjusted model demonstrated no correlation with the beneficial cardio-
renal-metabolic parameters in subjects with a high score of this pattern, except uric acid.
Rather, these subjects had high AST and ALT levels. This is possibly because higher consump-
tion of food could cancel the beneficial effects of habitual physical activity on cardio-renal met-
abolic parameters. These data suggest the presence of antagonistic effect of lifestyle patterns
that tend to accumulate in real daily life on cardio-renal-metabolic parameters.
Table 5. (Continued)
Variable Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Est Est1 Est2
baPWV (cm/s) 1568 ± 317 1523 ± 278 1532 ± 280 1539 ± 266 1554 ± 255 -1.22 -8.18 -8.39
Data are mean±SD, median [range: 25% to 75%] or number of subjects (proportion) before adjustment. Est1: Trend estimation for linear trends across
quintiles is based on linear regression analysis for continuous variables or logistic regression analysis for categorical variables. Est2: Trend estimation for
linear trends across quintiles is based on linear regression analysis for continuous variables or logistic regression analysis for categorical variables adjusted
for age and gender. Est3: Trend estimation for linear trends across quintiles is based on linear regression analysis for continuous variables or logistic
regression analysis for categorical variables adjusted for age, gender and BMI. eGFR is adjusted for BMI.
*P<0.05,
†P<0.01,
¶P<0.001 for testing the trend.
For trend test, log-transformed AST, ALT,ɤ-GTP, UAE, and TG. See Table 3 for abbreviations.
doi:10.1371/journal.pone.0173540.t005
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The present study has certain limitation. First, the cross-sectional design does not allow
inference of causal relationship between lifestyle patterns and cardio-renal-metabolic param-
eters. Also, we could not exclude the possibility that subjects change their daily lifestyles at
other periods. Second, we did not confirm the validity and reproducibility of the lifestyle pat-
terns found in this study in a different Japanese population. In this regard, we assessed the
validity and reproducibility of the lifestyle patterns in this study by the following steps: 1)
Subjects data in this study were randomly divided into two datasets (test and validation
Table 6. Multivariate regression analysis adjusted for age, gender and BMI.
Variable Lifestyle pattern Standrized regression coefficient P value
AST (U/L) (logarithmic transformation) type 1 -0.15 0.88
type 2 2.37 0.018
type 3 1.63 0.1
ALT (U/L) (log) (logarithmic transformation) type 1 1.45 0.15
type 2 -0.17 0.86
type 3 1.91 0.057
ɤ-GTP (U/L) (logarithmic transformation) type 1 0.16 0.88
type 2 5.30 <0.001
type 3 -1.09 0.28
Uric Acid (mg/dl) type 1 0.15 0.88
type 2 1.32 0.19
type 3 -1.48 0.14
Total cholesterol (mg/dl) type 1 -0.23 0.82
type 2 0.17 0.86
type 3 0.98 0.33
HDL-C (mg/dl) type 1 -0.31 0.75
type 2 3.71 <0.001
type 3 0.86 0.39
Triglycerides (mg/dl) (logarithmic transformation) type 1 0.90 0.37
type 2 1.98 0.048
type 3 -0.78 0.44
HbA1c (%) type 1 2.39 0.017
type 2 -1.13 0.26
type 3 0.77 0.44
Systolic BP (mmHg) type 1 2.17 0.03
type 2 1.72 0.086
type 3 -0.10 0.92
Diastolic BP (mmHg) type 1 0.73 0.47
type 2 2.22 0.027
type 3 -0.82 0.41
UAE (mg/g creatinine) (logarithmic transformation) type 1 0.87 0.38
type 2 1.44 0.15
type 3 0.26 0.79
baPWV (cm/s) type 1 1.99 0.047
type 2 0.59 0.55
type 3 -1.09 0.28
See Table 3 for abbreviations.
doi:10.1371/journal.pone.0173540.t006
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groups) in half, 2) The lifestyle patterns were evaluated by factor analysis in each dataset, and
3) Steps 1) and 2) were repeated ten times. According to this analysis, the lifestyle patterns
evaluated by factor analysis in test and validation groups were similar, and the results were
almost identical to those in the whole population (data not shown), suggesting that validity
and reproducibility of the lifestyle patterns were relatively high in an internal. Finally, there
may be other lifestyle patterns that should be considered, although based on the results of
previous reports, we chose the possible lifestyle factors related to cardio-renal—metabolic
parameters such as sleep quality [10,39], morningness-eveningness trait [14,40,41], depres-
sion status [17,18], energy intake and physical activity [3–5], smoking [42] and alcohol con-
sumption [43].
Conclusions
The present study identified three clustering of lifestyle patterns and confirmed the relation-
ship between such patterns and cardio-renal-metabolic parameters in T2DM patients free of
history of CVD. The results highlight the importance of intervention to modifiable lifestyles
based on their complex lifestyle pattern in daily life, in order to achieve appropriate cardio-
renal-metabolic functions and prevent future CVD in patients with T2DM.
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